Compare DRCT & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRCT | VTAK |
|---|---|---|
| Founded | 2018 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0M | 1.8M |
| IPO Year | 2021 | 2018 |
| Metric | DRCT | VTAK |
|---|---|---|
| Price | $2.61 | $0.26 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $32.00 | N/A |
| AVG Volume (30 Days) | 15.0K | ★ 9.0M |
| Earning Date | 05-08-2026 | 08-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 89.53 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $34,694,000.00 | $442,000.00 |
| Revenue This Year | $5.42 | $1,170.33 |
| Revenue Next Year | $9.50 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 3057.14 |
| 52 Week Low | $0.04 | $0.15 |
| 52 Week High | $7.21 | $4.31 |
| Indicator | DRCT | VTAK |
|---|---|---|
| Relative Strength Index (RSI) | 42.81 | 30.75 |
| Support Level | $2.51 | N/A |
| Resistance Level | $3.02 | $1.12 |
| Average True Range (ATR) | 0.14 | 0.17 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 51.00 | 1.36 |
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.
Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.